Cargando…
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It is currently coming to light that patients with psoriasis have disrupted intestinal barrier and often suffer from comorbidities associated with the gastrointestinal tract. Moreover, there is growing eviden...
Autores principales: | Jiraskova Zakostelska, Zuzana, Reiss, Zuzana, Tlaskalova-Hogenova, Helena, Rob, Filip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060503/ https://www.ncbi.nlm.nih.gov/pubmed/36929119 http://dx.doi.org/10.1007/s13555-023-00904-4 |
Ejemplares similares
-
Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis
por: Klimesova, Klara, et al.
Publicado: (2018) -
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy
por: Reiss, Zuzana, et al.
Publicado: (2023) -
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response
por: Coufal, Stepan, et al.
Publicado: (2019) -
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy
por: Schierova, Dagmar, et al.
Publicado: (2021) -
Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD
por: Coufal, Stepan, et al.
Publicado: (2023)